Nearly all those who have Medicare Advantage plans must deal with prior authorization. Now more prior authorization issues are appearing with Part D prescription drugs.

As healthcare AI evolves, there will be a greater emphasis on streamlining administrative tasks, drug production and service ...

Chief Executive Officer of Mineralys Therapeutics. “Prior studies have shown that even modest reductions in systolic blood pressure can lead to a substantial decrease in the incidence of major ...

Cullinan Therapeutics. “The results from REZILIENT1 show zipalertinib demonstrated clinically meaningful efficacy and a manageable safety profile in patients who have received prior platinum ...

Fintel reports that on April 21, 2025, Wolfe Research upgraded their outlook for Intellia Therapeutics (NasdaqGM ... 11% ownership of the company. In its prior filing, the firm reported owning ...

His prior board experience includes Paratek Pharmaceutical and Veloxis Inc. "I'm delighted to join Monument Therapeutics at such an exciting time in its growth," said Mr Radie. "The company's ...

Click here for more stories. Legislation focused on prior authorization reforms is headed to the governor after Senate lawmakers approved changes to the bill Wednesday. Lawmakers said the bill is ...

Legislation focused on prior authorization reforms is headed to the governor after Senate lawmakers approved changes to the bill Wednesday. Lawmakers said the bill is an important step in ...